PIPS Key Facts
| Active Substance |
- Pneumococcal Polysaccharide Serotype 1 - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 3 - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 4 - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 5 - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 6A - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 6B - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 7F - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 9V - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 14 - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 18C - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 19A - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 19F - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 22F - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 23F - Diphtheria CRM197 Conjugate
- Pneumococcal Polysaccharide Serotype 33F - Diphtheria CRM197 Conjugate
|
Invented Name
|
Not available at present
|
| PIP Number |
MHRA-100161-PIP01-21-M01 (update) |
|
Pharmaceutical form(s)
|
Pharmaceutical form(s):
|
|
Therapeutic area
|
Therapeutic area:
|
|
Conditions / Indications
|
Conditions / Indications:
- Prevention of disease caused by Streptococcus pneumoniae
|
|
Route(s) of administration
|
Route(s) of administration:
|
|
PIP applicant
|
|
|
Decision Type
|
Decision Type
PM: decision on the application for modification of an agreed paediatric investigation plan.
|
|
Compliance Check
|
|
|
Compliance Check Decision Date
|
Compliance opinion date
29/07/2022
|
|
Compliance Check Procedure Number
|
Compliance procedure number
MHRA-100161-PIP01-21-M01-C
|